'Pd 1' diaporamas de présentation

Lupus nephritis

Lupus nephritis. review. Introduction. Tissue injury can affect nearly everyorgan, however, it is the damage to the kidney that is largely responsible for morbidity and mortality Within the kidney the expression of SLE is heterogeneous.

750 views • 55 slides

??? ??????

CD. ????????. ??? ??????. HLDA/CD ?? HLDA8 ??? CD ?? ?? CD ????????? trafficking ????? CD4 + T ???? IgSF ???????????? Siglec ?? CD226 ???? HLDA9. ???? ( ????? ). ?? Ag. ?? ??. + MHC. ??? ? ?. Ag Ig ???? ????. ???? ????. TNF SF. IgFc ??. ?? ??. ?? NK

847 views • 40 slides

From Care to Cure Nicolas Chomont, PhD

919 views • 39 slides

?????? ???????????

Synthesis and Characterization of N-Heterocyclic Carbene Palladium(II) Complexes. The Catalytic Application on Strecker Synthesis of ?- aminonitriles. ?????? ???????????. 2010 / 05 / 17 Department of Chemistry & Biochemistry Chung Cheng University. Phosphine Ligand.

583 views • 37 slides

473 views • 36 slides

467 views • 31 slides

Immunotherapy for Cancer

Immunotherapy for Cancer. Success At Last! Russell M. Eldridge MD. What is Immunotherapy, and why is everyone talking about it?. An old idea finally delivers the biggest breakthrough in cancer treatment in the last 30 years. Brief History of Cancer Treatments. Surgery is the oldest

621 views • 30 slides

Are Combinations the Solution: Perspectives on Combination Immunotherapy

Are Combinations the Solution: Perspectives on Combination Immunotherapy.

445 views • 28 slides

Immune therapy in NSCLC

495 views • 28 slides

PHARE Operational Scenarios

PHARE Operational Scenarios. J-P. Nicolaon, Operational Task Force Chairman EUROCONTROL Experimental Centre. Overview of the work on PHARE scenarios. PHARE Medium Term Scenario (Research Programme) : Initial operational organisation based on :. JULY 1990. Human in the loop 4D Navigation

402 views • 26 slides

365 views • 25 slides

Price Discrimination

376 views • 24 slides

Joseph Conrad Kalams Laboratory Microbiology and Immunology Vanderbilt University

PD-1 expression is increased on dominant T-cell clonotypes within epitope-specific T-cell populations in chronic HIV infection. Joseph Conrad Kalams Laboratory Microbiology and Immunology Vanderbilt University Nashville, TN USA. TCR. HIV peptide. MHC-I. Clements, Curr Opp Str Bio, 2006.

259 views • 13 slides

Thought for the Week :

282 views • 13 slides

276 views • 12 slides

Westin JR et al. Proc ASH 2012; Abstract 793.

Phase II Safety and Efficacy Study of CT-011, a Humanized Anti-PD-1 Monoclonal Antibody, in Combination with Rituximab in Patients with Relapsed Follicular Lymphoma. Westin JR et al. Proc ASH 2012; Abstract 793. Background.

284 views • 9 slides

Gianni L et al. Proc SABCS 2012 ; Abstract GS6-7.

Adaptive Immune System and Immune Checkpoints Are Associated with Response to Pertuzumab (P) and Trastuzumab (H) in the NeoSphere Study. Gianni L et al. Proc SABCS 2012 ; Abstract GS6-7. Background.

236 views • 9 slides

Nivolumab

Nivolumab. Drugbank ID : DB 09035 Molecular Weight (Daltons) : 143597.381 Chemical Formula : C6362H9862N1712O1995S42 Half life : 26.7 days Description :

725 views • 6 slides

Project: IEEE P802.15 Working Group for Wireless Personal Area Networks (WPANs)

Project: IEEE P802.15 Working Group for Wireless Personal Area Networks (WPANs) Submission Title: [Complementary frame structure for TDD mode] Date Submitted: [ November 2013] Source: [Marco Hernandez, Huan -Bang Li, Igor Dotli? , Ryu Miura ] Company: [ NICT]

126 views • 5 slides

High Affinity HIV-1 Specific CTL Become Exhausted in Early HIV-1 Infection

High Affinity HIV-1 Specific CTL Become Exhausted in Early HIV-1 Infection.

108 views • 1 slides